- Maintenance treatment in chronic asthma (alone or in combination with a beta-2agonist bronchodilator):
- Adult: 1-4 puffs BD depending on severity
- Child: 50mcg BD.
- Max 200mcg/day
- Inhaler
- 50mcg/puff
- 100mcg/puff
- Actuate before use by pumping 2 puffs in the air before use.
- Shake for 5 seconds before each use.
- Prime inhaler again if not used for >7 days
- Rinse mouth with water after use.
- Taper to withdraw
Glucocorticoid.
It inhibits inflammatory cells and release of inflammatory mediators
- Headache
- Pharyngitis
- URI
- Rhinitis
- Sinusitis
- Pain
- Back pain
- Nausea
- Dysphonia
- Dysmenorrhea
- Cough
- Oral candidiasis
- Hypersensitivity to drug or ingredient
- Status asthmaticus
- Acute asthma
- Acute bronchospasm
- Abrupt withdrawal
- Desmopressin
Drug Status
| Availability | Prescription only |
| Pregnancy | Weigh risk vs benefit otherwise contraindicated |
| Breastfeeding | Can be used |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Beclomin 100 | 100mcg/puff | Inhalation | 200D | Square Pharma | Ace Pharma |
| Becort | 200mcg/puff | Inhalation | 200D | Cipla Ltd | Imperial Managed |
| Decomit 100 HFA | 100mcg/puff | Inhalation | 200D | Beximco Pharma | Madawa Pharma |
| Decomit 50 HFA | 50mcg/puff | Inhalation | 200D | Beximco Pharma | Madawa Pharma |
| Decomit Nasal Spray | 50mcg/puff | Nasal Spray | 200D | Beximco Pharma | Madawa Pharma |